ISBN: 9798907224155 - pharmaceutical regulatory affairs: drug development, approval and clinical research for b.pharm semester vii | course code (8 risultati)

Perfeziona la tua ricerca

  • Libri (8)

  • Nuovo (8)

a

Fascia di prezzo personalizzata (EUR)

a

  • Condizione: Nuovo

    EUR 37,59

    EUR 2,67 spedizione 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New.

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 39,94

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 41,97

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. Pharmaceutical development is governed not only by scientific discovery, but by the regulatory evidence required to establish quality, safety, efficacy and responsible clinical use. Written for B.Pharm Semester VII students under the PCI 2026 framework, this textbook develops Regulatory Affairs as an applied pharmaceutical discipline linking drug development, regulatory decision-making and protection of public health.The text progresses from regulatory principles, terminology and major authorities to drug discovery, non-clinical evaluation, regulatory documentation and clinical development.It examines CDSCO and State Licensing Authorities in India, international agencies including the US FDA, EMA and PMDA, IND, NDA and ANDA pathways, Drug Master Files, bioequivalence, generic and phytopharmaceutical regulation, CTD, eCTD and ACTD submissions, overseas registration and post-approval changes. Clinical research phases, IRB and IEC functions, informed consent, Good Clinical Practice, trial monitoring and pharmacovigilance are integrated within the wider product lifecycle.Clear explanations emphasise why regulatory requirements exist, how evidence is generated and documented, and how regulators use that evidence in review and approval. Jurisdiction-specific concepts are carefully distinguished, while historical provisions are placed in appropriate context. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 36,65

    EUR 6,02 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: CitiRetail, Stevenage, Regno UnitoCitiRetail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 41,37

    EUR 44,38 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. Pharmaceutical development is governed not only by scientific discovery, but by the regulatory evidence required to establish quality, safety, efficacy and responsible clinical use. Written for B.Pharm Semester VII students under the PCI 2026 framework, this textbook develops Regulatory Affairs as an applied pharmaceutical discipline linking drug development, regulatory decision-making and protection of public health.The text progresses from regulatory principles, terminology and major authorities to drug discovery, non-clinical evaluation, regulatory documentation and clinical development.It examines CDSCO and State Licensing Authorities in India, international agencies including the US FDA, EMA and PMDA, IND, NDA and ANDA pathways, Drug Master Files, bioequivalence, generic and phytopharmaceutical regulation, CTD, eCTD and ACTD submissions, overseas registration and post-approval changes. Clinical research phases, IRB and IEC functions, informed consent, Good Clinical Practice, trial monitoring and pharmacovigilance are integrated within the wider product lifecycle.Clear explanations emphasise why regulatory requirements exist, how evidence is generated and documented, and how regulators use that evidence in review and approval. Jurisdiction-specific concepts are carefully distinguished, while historical provisions are placed in appropriate context. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 56,86

    EUR 32,93 spedizione 
    Spedito da Australia a U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. Pharmaceutical development is governed not only by scientific discovery, but by the regulatory evidence required to establish quality, safety, efficacy and responsible clinical use. Written for B.Pharm Semester VII students under the PCI 2026 framework, this textbook develops Regulatory Affairs as an applied pharmaceutical discipline linking drug development, regulatory decision-making and protection of public health.The text progresses from regulatory principles, terminology and major authorities to drug discovery, non-clinical evaluation, regulatory documentation and clinical development.It examines CDSCO and State Licensing Authorities in India, international agencies including the US FDA, EMA and PMDA, IND, NDA and ANDA pathways, Drug Master Files, bioequivalence, generic and phytopharmaceutical regulation, CTD, eCTD and ACTD submissions, overseas registration and post-approval changes. Clinical research phases, IRB and IEC functions, informed consent, Good Clinical Practice, trial monitoring and pharmacovigilance are integrated within the wider product lifecycle.Clear explanations emphasise why regulatory requirements exist, how evidence is generated and documented, and how regulators use that evidence in review and approval. Jurisdiction-specific concepts are carefully distinguished, while historical provisions are placed in appropriate context. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 57,39

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceutical development is governed not only by scientific discovery, but by the regulatory evidence required to establish quality, safety, efficacy and responsible clinical use. Written for B.Pharm Semester VII students under the PCI 2026 framework, this textbook develops Regulatory Affairs as an applied pharmaceutical discipline linking drug development, regulatory decision-making and protection of public health.The text progresses from regulatory principles, terminology and major authorities to drug discovery, non-clinical evaluation, regulatory documentation and clinical development.It examines CDSCO and State Licensing Authorities in India, international agencies including the US FDA, EMA and PMDA, IND, NDA and ANDA pathways, Drug Master Files, bioequivalence, generic and phytopharmaceutical regulation, CTD, eCTD and ACTD submissions, overseas registration and post-approval changes. Clinical research phases, IRB and IEC functions, informed consent, Good Clinical Practice, trial monitoring and pharmacovigilance are integrated within the wider product lifecycle.Clear explanations emphasise why regulatory requirements exist, how evidence is generated and documented, and how regulators use that evidence in review and approval. Jurisdiction-specific concepts are carefully distinguished, while historical provisions are placed in appropriate context.…

  • Lingua: Inglese

    Editore: Notion Press, 2026

    9798907224155

    • Brossura
    • Print on Demand

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 44,75

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. Pharmaceutical Regulatory Affairs | Drug Development, Approval and Clinical Research For [.] Semester VII Course Code: BP707T | Putta Ravi (u. a.) | Taschenbuch | Englisch | 2026 | Notion Press | EAN 9798907224155 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …